PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Chlorobutanol→

Chlorobutanol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
57-15-8
Molecular formula
C4H7Cl3O
Molecular weight
177.45 g/mol
Drug class
Halogenated tertiary alcoholpharmaceutical preservative with local anaesthetic properties
Mechanism of action
Exerts antimicrobial preservative activity in aqueous pharmaceutical solutions. At local concentrations it may also produce mild local anaesthetic effects; activity and safety depend on formulation and route.
Indications / reported uses
  • Used primarily as an antimicrobial preservative in ophthalmic, otic and other pharmaceutical formulations; some historical topical preparations used it as a local anaesthetic ingredient. It should not be assigned a general systemic therapeutic indication.

Sources: NLM MeSH — Chlorobutanol · PubChem — Chlorobutanol · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Chlorobutanol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chlorobutanol Permitted Daily Exposure (PDE) report (the Chlorobutanol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chlorobutanol Occupational Exposure Limit (OEL) report (the Chlorobutanol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.